132 related articles for article (PubMed ID: 21125389)
21. Processing of N-terminal unnatural amino acids in recombinant human interferon-beta in Escherichia coli.
Wang A; Winblade Nairn N; Johnson RS; Tirrell DA; Grabstein K
Chembiochem; 2008 Jan; 9(2):324-30. PubMed ID: 18098265
[TBL] [Abstract][Full Text] [Related]
22. Lantibiotic transporter requires cooperative functioning of the peptidase domain and the ATP binding domain.
Nishie M; Sasaki M; Nagao J; Zendo T; Nakayama J; Sonomoto K
J Biol Chem; 2011 Apr; 286(13):11163-9. PubMed ID: 21303905
[TBL] [Abstract][Full Text] [Related]
23. Modification of the amaranth 11S globulin storage protein to produce an inhibitory peptide of the angiotensin I converting enzyme, and its expression in Escherichia coli.
Luna-Suárez S; Medina-Godoy S; Cruz-Hernández A; Paredes-López O
J Biotechnol; 2010 Aug; 148(4):240-7. PubMed ID: 20561545
[TBL] [Abstract][Full Text] [Related]
24. Unique peptide modifications involved in the biosynthesis of lantibiotics.
Jack RW; Sahl HG
Trends Biotechnol; 1995 Jul; 13(7):269-78. PubMed ID: 7646850
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of essential and variable residues of nukacin ISK-1 by NNK scanning.
Islam MR; Shioya K; Nagao J; Nishie M; Jikuya H; Zendo T; Nakayama J; Sonomoto K
Mol Microbiol; 2009 Jun; 72(6):1438-47. PubMed ID: 19432794
[TBL] [Abstract][Full Text] [Related]
26. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
Hatfield GW; Roth DA
Biotechnol Annu Rev; 2007; 13():27-42. PubMed ID: 17875472
[TBL] [Abstract][Full Text] [Related]
27. Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes.
van Heel AJ; Mu D; Montalbán-López M; Hendriks D; Kuipers OP
ACS Synth Biol; 2013 Jul; 2(7):397-404. PubMed ID: 23654279
[TBL] [Abstract][Full Text] [Related]
28. Bioprocess-centered molecular design (BMD) for the efficient production of an interfacially active peptide.
Morreale G; Lee EG; Jones DB; Middelberg AP
Biotechnol Bioeng; 2004 Sep; 87(7):912-23. PubMed ID: 15334418
[TBL] [Abstract][Full Text] [Related]
29. Expression and characterization of a His-tagged 11S seed globulin from Amaranthus hypochondriacus in Escherichia coli.
Medina-Godoy S; Nielsen NC; Paredes-López O
Biotechnol Prog; 2004; 20(6):1749-56. PubMed ID: 15575708
[TBL] [Abstract][Full Text] [Related]
30. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.
Bierbaum G; Szekat C; Josten M; Heidrich C; Kempter C; Jung G; Sahl HG
Appl Environ Microbiol; 1996 Feb; 62(2):385-92. PubMed ID: 8593044
[TBL] [Abstract][Full Text] [Related]
31. Structure-function relationships of the lanthionine cyclase SpaC involved in biosynthesis of the Bacillus subtilis peptide antibiotic subtilin.
Helfrich M; Entian KD; Stein T
Biochemistry; 2007 Mar; 46(11):3224-33. PubMed ID: 17305367
[TBL] [Abstract][Full Text] [Related]
32. Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production.
Chatterjee C; Miller LM; Leung YL; Xie L; Yi M; Kelleher NL; van der Donk WA
J Am Chem Soc; 2005 Nov; 127(44):15332-3. PubMed ID: 16262372
[TBL] [Abstract][Full Text] [Related]
33. Biosynthesis of lantibiotic nisin. Posttranslational modification of its prepeptide occurs at a multimeric membrane-associated lanthionine synthetase complex.
Siegers K; Heinzmann S; Entian KD
J Biol Chem; 1996 May; 271(21):12294-301. PubMed ID: 8647829
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids.
Nickling JH; Baumann T; Schmitt FJ; Bartholomae M; Kuipers OP; Friedrich T; Budisa N
J Vis Exp; 2018 May; (135):. PubMed ID: 29781997
[TBL] [Abstract][Full Text] [Related]
35. D-Amino acid dipeptide production utilizing D-alanine-D-alanine ligases with novel substrate specificity.
Sato M; Kirimura K; Kino K
J Biosci Bioeng; 2005 Jun; 99(6):623-8. PubMed ID: 16233841
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.
Aso Y; Sashihara T; Nagao J; Kanemasa Y; Koga H; Hashimoto T; Higuchi T; Adachi A; Nomiyama H; Ishizaki A; Nakayama J; Sonomoto K
Biosci Biotechnol Biochem; 2004 Aug; 68(8):1663-71. PubMed ID: 15322349
[TBL] [Abstract][Full Text] [Related]
37. Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.
Aso Y; Nagao J; Koga H; Okuda K; Kanemasa Y; Sashihara T; Nakayama J; Sonomoto K
J Biosci Bioeng; 2004; 98(6):429-36. PubMed ID: 16233732
[TBL] [Abstract][Full Text] [Related]
38. Rational redesign of porcine pepsinogen containing an antimicrobial peptide.
Bryksa BC; Horimoto Y; Yada RY
Protein Eng Des Sel; 2010 Sep; 23(9):711-9. PubMed ID: 20601363
[TBL] [Abstract][Full Text] [Related]
39. Heterologous Expression of Mersacidin in
Viel JH; Jaarsma AH; Kuipers OP
ACS Synth Biol; 2021 Mar; 10(3):600-608. PubMed ID: 33689311
[TBL] [Abstract][Full Text] [Related]
40. Nukacin 3299, a lantibiotic produced by Staphylococcus simulans 3299 identical to nukacin ISK-1.
Ceotto H; Holo H; da Costa KF; Nascimento Jdos S; Salehian Z; Nes IF; Bastos Mdo C
Vet Microbiol; 2010 Nov; 146(1-2):124-31. PubMed ID: 20627619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
